Literature DB >> 27344000

A systematic review comparing sex differences in cognitive function in schizophrenia and in rodent models for schizophrenia, implications for improved therapeutic strategies.

Marianne Leger1, Joanna C Neill2.   

Abstract

Sex is often overlooked in animal and human research. Cognitive impairment associated with schizophrenia (CIAS) remains an unmet clinical need, as current antipsychotic medication does not provide clinically meaningful improvements. One explanation could be lack of appreciation of gender differences in CIAS. Animal models play a critical role in drug development and improved translation to the clinic is an on-going process. Our systematic review aims to evaluate how well the animal studies translate into clinical findings. Supporting clinical results, our review highlights a male working memory advantage and a female advantage for visual memory and social cognition in rodent models for schizophrenia. Not investigated in animals, a female advantage for attention and speed of processing has been found in schizophrenia patients. Sex differences in reasoning and problem solving are poorly investigated in both human and animal studies. Overall, our review provides evidence of good translation from the animal models into the clinic when sexual dimorphism is assessed. Enhanced understanding of these sex differences will improve the management of CIAS.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Attention; Cognition; Gender or sex differences; Human; Mice; Rats; Reasoning and problem solving; Schizophrenia; Social cognition; Speed of processing; Visual learning and memory; Working and short-term memory

Mesh:

Year:  2016        PMID: 27344000     DOI: 10.1016/j.neubiorev.2016.06.029

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  13 in total

1.  A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study.

Authors:  Yange Li; Lei Zhang; Yan Zhang; Hui Wen; Jingjing Huang; Yifeng Shen; Huafang Li
Journal:  Neuropsychiatr Dis Treat       Date:  2021-03-19       Impact factor: 2.570

2.  Exposure to elevated embryonic kynurenine in rats: Sex-dependent learning and memory impairments in adult offspring.

Authors:  Silas A Buck; Annalisa M Baratta; Ana Pocivavsek
Journal:  Neurobiol Learn Mem       Date:  2020-07-30       Impact factor: 2.877

Review 3.  Sex differences in stress reactivity in arousal and attention systems.

Authors:  Debra A Bangasser; Samantha R Eck; Evelyn Ordoñes Sanchez
Journal:  Neuropsychopharmacology       Date:  2018-06-29       Impact factor: 7.853

4.  Antioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine Treatment.

Authors:  Aarron Phensy; Hasmik E Duzdabanian; Samantha Brewer; Anurag Panjabi; Christopher Driskill; Annuska Berz; George Peng; Sven Kroener
Journal:  Front Behav Neurosci       Date:  2017-06-06       Impact factor: 3.558

5.  Similar reliability and equivalent performance of female and male mice in the open field and water-maze place navigation task.

Authors:  Ann-Kristina Fritz; Irmgard Amrein; David P Wolfer
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-06-27       Impact factor: 3.908

6.  Interactive effect of MTHFR C677T polymorphism and sex on symptoms and cognitive functions in Chinese patients with chronic schizophrenia.

Authors:  Jie Gao; Mei Hong Xiu; Dian Ying Liu; Chang Wei Wei; Xiangyang Zhang
Journal:  Aging (Albany NY)       Date:  2020-06-04       Impact factor: 5.682

7.  Integrative Transcriptomics Reveals Sexually Dimorphic Control of the Cholinergic/Neurokine Interface in Schizophrenia and Bipolar Disorder.

Authors:  Sebastian Lobentanzer; Geula Hanin; Jochen Klein; Hermona Soreq
Journal:  Cell Rep       Date:  2019-10-15       Impact factor: 9.423

8.  Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer's disease.

Authors:  Hai-Yong Liang; Pei-Pei Zhang; Xi-Le Zhang; Yan-Yan Zheng; Yan-Ran Huang; Guo-Qing Zheng; Yan Lin
Journal:  Aging (Albany NY)       Date:  2021-03-03       Impact factor: 5.682

9.  Sex differences in the association of body mass index with symptoms and cognitive deficits in Chinese patients with chronic schizophrenia.

Authors:  Chang Wei Wei; Ying Qi Chen; Mi Ma; Mei Hong Xiu; Xiang Yang Zhang
Journal:  Transl Psychiatry       Date:  2020-01-21       Impact factor: 6.222

10.  Functional Dysregulations in CA1 Hippocampal Networks of a 3-Hit Mouse Model of Schizophrenia.

Authors:  Solenn Percelay; Jean-Marie Billard; Thomas Freret; Annie Andrieux; Michel Boulouard; Valentine Bouet
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.